{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:00Z","timestamp":1791924180470,"version":"4.3.4"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>The purpose of this study was to assess the effects of renin\u2010angiotensin system (<jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>) inhibitors vs other antihypertensive agents on cardiovascular outcomes in hypertensive black patients. The authors performed a systematic review and meta\u2010analysis of studies that compared the effects of angiotensin\u2010converting enzyme (<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>) inhibitors or angiotensin receptor blockers (<jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>s) with calcium channel blockers (<jats:styled-content style=\"fixed-case\">CCB<\/jats:styled-content>s), diuretics, and \u03b2\u2010blockers in hypertensive black patients on cardiovascular outcomes. A total of 38,983 patients with a mean age of 60\u00a0years and mean follow\u2010up of 4\u00a0years were included in our meta\u2010analysis. No significant differences were found in all\u2010cause mortality, myocardial infarction, heart failure, and cardiovascular mortality rates among patients treated with <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content> inhibitors compared with <jats:styled-content style=\"fixed-case\">CCB<\/jats:styled-content>s, diuretics, and \u03b2\u2010blockers. The incidence of stroke was significantly increased in patients treated with <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content> inhibitors compared with <jats:styled-content style=\"fixed-case\">CCB<\/jats:styled-content>s (odds ratio, 1.56; 95% confidence interval, 1.31\u20131.87 [<jats:italic>P<\/jats:italic>&lt;.00001]; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>=0%) and diuretics (odds ratio, 1.59; 95% confidence interval, 1.16\u20132.17 [<jats:italic>P<\/jats:italic>=.004]; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>=56%) but not \u03b2\u2010blockers.<\/jats:p>","DOI":"10.1111\/jch.12867","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T04:27:13Z","timestamp":1467692833000},"page":"344-350","source":"Crossref","is-referenced-by-count":12,"title":["Renin\u2010Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta\u2010Analysis"],"prefix":"10.1111","volume":"19","author":[{"given":"Mohan","family":"Palla","sequence":"first","affiliation":[{"name":"Division of the Cardiology Wayne State University School of Medicine Detroit MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of the Cardiology Wayne State University School of Medicine Detroit MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Androulakis","sequence":"additional","affiliation":[{"name":"John Radcliffe Hospital University of Oxford Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye","family":"Telila","sequence":"additional","affiliation":[{"name":"Division of the Cardiology Wayne State University School of Medicine Detroit MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[{"name":"Division of the Cardiology Wayne State University School of Medicine Detroit MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.152892"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-8-200410190-00009"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.04.020"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304013281303"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jama.1992.03480090069029","article-title":"Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy","volume":"267","author":"Blaufox MD","year":"1992","journal-title":"JAMA"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.04.034"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.11.029"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1595"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.08.004"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2003.08.015"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031037.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000024349.85680.87"},{"key":"e_1_2_8_16_1","volume-title":"Comprehensive Clinical Nephrology","author":"Flack JM","year":"1998"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.5.1088"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000127924.67353.86"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-201"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140265.21608.8E"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000137160.76616.cc"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00450.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000578"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1185\/0300799009117011"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.417"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.12867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.12867","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.12867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:47:25Z","timestamp":1696286845000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.12867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/jch.12867"],"URL":"https:\/\/doi.org\/10.1111\/jch.12867","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]}}}